Prathap Nagaraja Shastri

Author

Janssen (United States)

Also Known As

Prathap Nagaraja Shastri, Prathap Shastri

Publications

265

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Mercer University Health Sciences Center Mercer University

About

Prathap Nagaraja Shastri is an author at Janssen (United States) specializing in medicine, pharmacology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	81
2	Engineering	1	1	26
3	Biomedical Engineering	1	1	26
4	Gastroenterology	1	1	21
5	Immunology	1	1	34

Prathap Nagaraja Shastri

Publications

189

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity and protection of oral influenza vaccines formulated into microparticles Prathap Nagaraja Shastri, Minchul Kim, Fu‐Shi Quan, Journal of Pharmaceutical Sciences VaccinationOral Influenza VaccinesCross-protectionMucosal VaccinationImmunology	2012	34
Nonclinical Development of Next-generation Site-specific HER2-targeting Antibody–drug Conjugate (ARX788) for Breast Cancer Treatment Prathap Nagaraja Shastri, Jingjing Zhu, Lillian Skidmore, Molecular Cancer Therapeutics	2020	29
Development and evaluation of polycaprolactone based docetaxel nanoparticle formulation for targeted breast cancer therapy Lakshmi Prasanna Kolluru, Thripthy Chandran, Prathap Nagaraja Shastri, Journal of Nanoparticle Research NanoparticlesNanomedicineEngineeringPolymer-drug ConjugateMedicine	2020	26
Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles Prathap Nagaraja Shastri, Ruhi V. Ubale, Martin J. D’Souza Drug Development and Industrial Pharmacy	2012	25
Bleximenib Dose Optimization and Determination of RP2D from a Phase 1 Study in Relapsed/Refractory Acute Leukemia Patients with <i>KMT2A</i> and <i>NPM1</i> Alterations Emma Searle, Christian Récher, Maher Abdul‐Hay, Blood	2024	25
Increased bioavailability of celecoxib under fed versus fasted conditions is determined by postprandial bile secretion as demonstrated in a dynamic gastrointestinal model Eric Lyng, R. Havenaar, Prathap Nagaraja Shastri, Drug Development and Industrial Pharmacy NutritionGastroenterologyPathologyDigestive TractCelecoxib Bioaccessibility	2016	21
Clinical Pharmacology Perspective on Development of Adeno‐Associated Virus Vector‐Based Retina Gene Therapy Jennifer Lynn Ford, Eleni Karatza, Hardik Mody, Clinical Pharmacology & Therapeutics	2024	18
Preclinical Characterization of ARX517, a Site-Specific Stable PSMA-Targeted Antibody–Drug Conjugate for the Treatment of Metastatic Castration-Resistant Prostate Cancer Lillian Skidmore, David Mills, Ji Young Kim, Molecular Cancer Therapeutics	2024	11

Page 1